Publication

Number of items: 7.
30 May 2023
  • Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial. (2023) Simon J. Davies, David Coyle, Elizabeth J. Lindley, David Keane, John Belcher, Fergus J. Caskey, Indranil Dasgupta, Andrew Davenport, Ken Farrington, Sandip Mitra, Paula Ormandy, Martin Wilkie, Jamie MacDonald, Mandana Zanganeh, Lazaros Andronis, Ivonne Solis-Trapala and Julius Sim
    • 19 August 2021
  • A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. (2021) Enric Vilar, Raja M Kaja Kamal, James Fotheringham, Amanda Busby, Jocelyn Berdeprado, Ewa Kislowska, David Wellsted, Bassam Alchi, James O Burton, Andrew Davenport and Ken Farrington
    • 31 December 2016
  • A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all. (2016) Sally El-Kateb, Sivakumar Sridharan, Ken Farrington, Stanley Fan and Andrew Davenport picture_as_pdf
    • 16 February 2016
  • Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin. (2016) Jonathan Wong, Sivakumar Sridharan, Jocelyn Berdeprado, Adie Viljoen, Enric Vilar Hall, David Wellsted and Kenneth Farrington
    • 30 September 2015
  • The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. (2015) James Fotheringham, Damian G Fogarty, Meguid El Nahas, Michael J Campbell and Ken Farrington
    • 2010
  • The retained stent : forgotten but not gone. (2010) E.C. Jolly, J.M. Adshead and Ken Farrington
    • 2008
  • Kt/V underestimates the hemodialysis dose in women and small men. (2008) E.M. Spalding, S.M. Chandra, A. Davenport and Ken Farrington picture_as_pdf